Tag: Europe
-
BioNTech to Provide Personal Cancer Immunotherapies in UK
The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030.
-
Company Started for Gene Editing Rare Inherited Diseases
A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells.
-
Food Protein Biotech Adds €4M in Seed Funds
A new company creating protein ingredients for food products from carbon dioxide converted by engineered bacteria is raising €4 million more in seed funds.
-
Trial Begins Testing Digital Therapy for Anxiety with Lung Disease
A clinical trial is underway testing a mobile app designed to help people with a serious lung disorder manage anxiety that often accompanies the disease.
-
DNA Storage Start-Up Gains €5M in Seed Funds
A new company developing DNA as a data storage medium with sustainable processes is raising €5 million ($US 5.22 million) in seed funding.
-
Grant Funds Implanted Brain-Computer Spinal Injury Device
A project to develop a brain-computer device to stimulate upper and lower limb movement in people with spinal cord injuries is receiving a €3.7 million award.
-
Company to Boost Orphan Drugs in Europe
A start-up enterprise seeks to make drugs for treating rare diseases more readily available to physicians and patients in Europe.
-
Neurons Identified, Stimulated for Spinal Cord Repair
Spinal cord injury patients in a clinical trial received electronic stimulation to a specified set of nerve cells that enabled them to restore walking after rehabilitation.
-
Patent Awarded for Focused Ultrasound Skin Treatments
A company developing non-invasive ultrasound treatments for treating skin disorders and removing tattoos received a patent for its technology.
-
Trial in Progress of Antibody Blocking Covid-19 in Immunocompromised
A clinical trial is underway testing a synthetic antibody designed to prevent SARS-CoV-2 viral infections in people with compromised immune systems.